Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:EPPNASDAQ:HGENNYSE:INFA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEPPiShares MSCI Pacific ex Japan ETF$48.34+0.1%$47.01$38.44▼$50.04$1.81B0.86335,718 shs165,883 shsHGENHumanigen$0.00$0.00▼$0.24$24K-1.043.26 million shs2.06 million shsINFAInformatica$24.160.0%$20.74$15.65▼$31.65$7.31B1.172.74 million shs5.65 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEPPiShares MSCI Pacific ex Japan ETF0.00%-2.87%+0.54%+9.47%+11.72%HGENHumanigen0.00%0.00%0.00%0.00%0.00%INFAInformatica0.00%+0.10%+25.68%+32.90%-19.62%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEPPiShares MSCI Pacific ex Japan ETFN/AN/AN/AN/AN/AN/AN/AN/AHGENHumanigenN/AN/AN/AN/AN/AN/AN/AN/AINFAInformatica1.535 of 5 stars2.02.00.00.01.82.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEPPiShares MSCI Pacific ex Japan ETF 2.92Moderate Buy$48.34N/AHGENHumanigen 0.00N/AN/AN/AINFAInformatica 2.06Hold$24.461.27% UpsideCurrent Analyst Ratings BreakdownLatest HGEN, INFA, EPP, and JEL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025INFAInformaticaRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$25.005/28/2025INFAInformaticaRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$19.00 ➝ $25.005/28/2025INFAInformaticaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold$24.00 ➝ $25.005/28/2025INFAInformaticaJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$24.00 ➝ $25.005/28/2025INFAInformaticaWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$19.00 ➝ $25.005/28/2025INFAInformaticaWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/27/2025INFAInformaticaRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$19.00 ➝ $22.005/16/2025INFAInformaticaUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$20.00 ➝ $21.005/8/2025INFAInformaticaUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$19.00 ➝ $20.005/8/2025INFAInformaticaRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$20.00 ➝ $19.00(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEPPiShares MSCI Pacific ex Japan ETFN/AN/AN/AN/AN/AN/AHGENHumanigen$1.70M0.00N/AN/A($0.45) per share0.00INFAInformatica$1.64B4.46$0.79 per share30.69$6.64 per share3.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEPPiShares MSCI Pacific ex Japan ETFN/AN/A17.82∞N/AN/AN/AN/AN/AHGENHumanigen-$70.73MN/A0.00N/AN/AN/AN/AN/AN/AINFAInformatica$9.93M$0.03N/A35.015.850.12%5.89%2.66%7/29/2025 (Estimated)Latest HGEN, INFA, EPP, and JEL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025INFAInformatica$0.22$0.22N/AN/A$392.14 million$403.90 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEPPiShares MSCI Pacific ex Japan ETF$1.673.45%N/AN/AN/AHGENHumanigenN/AN/AN/AN/AN/AINFAInformaticaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEPPiShares MSCI Pacific ex Japan ETFN/AN/AN/AHGENHumanigenN/AN/AN/AINFAInformatica0.781.921.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEPPiShares MSCI Pacific ex Japan ETF74.75%HGENHumanigen4.55%INFAInformatica98.45%Insider OwnershipCompanyInsider OwnershipEPPiShares MSCI Pacific ex Japan ETFN/AHGENHumanigen21.70%INFAInformatica2.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEPPiShares MSCI Pacific ex Japan ETFN/A37.50 millionN/ANot OptionableHGENHumanigen6119.08 million93.24 millionNo DataINFAInformatica5,200302.60 million294.13 millionOptionableHGEN, INFA, EPP, and JEL HeadlinesRecent News About These CompaniesDealmaking in 2025: AI to the rescueJune 19 at 7:49 AM | msn.comInformatica Inc. (INFA) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky InvestigatesJune 17 at 10:00 AM | accessnewswire.comFIVN vs. INFA: Which Stock Is the Better Value Option?June 16, 2025 | zacks.comDisplaying items by tag: Managed Iceberg TablesJune 16, 2025 | itwire.comInformatica Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - INFAJune 16, 2025 | accessnewswire.comDisplaying items by tag: Mosaic AI integrationsJune 16, 2025 | itwire.comDisplaying items by tag: GenAI applicationJune 16, 2025 | itwire.comInformatica's SWOT analysis: cloud data firm's stock in focus amid buyoutJune 13, 2025 | investing.comINFA STOCK ALERT: Levi & Korsinsky Notifies Informatica Inc. Investors of an Ongoing InvestigationJune 13, 2025 | accessnewswire.comInformatica’s Insider Shake-Up: CAO Cashes In on Stock SaleJune 12, 2025 | tipranks.comInformatica Expands Partnership with Databricks as Launch Partner for Managed Iceberg Tables and OLTP Database Service at Data + AI Summit 2025June 12, 2025 | finance.yahoo.comInformatica Inc. Being Investigated on Behalf of Informatica Inc. Investors. Contact Levi & Korsinsky For DetailsJune 12, 2025 | accessnewswire.comGAMMA Investing LLC Purchases 19,005 Shares of Informatica Inc. (NYSE:INFA)June 12, 2025 | marketbeat.comCantor Fitzgerald Comments on Informatica FY2026 EarningsJune 12, 2025 | americanbankingnews.comBrokerages Set Informatica Inc. (NYSE:INFA) PT at $24.46June 12, 2025 | americanbankingnews.comIs Salesforce Stock A Buy In 2025? 3 Key Drivers Behind Its AI And Profitability Push June 11, 2025 | talkmarkets.comIBM Tried to Acquire Informatica before Salesforce (CRM)June 11, 2025 | theglobeandmail.comINFA ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Informatica Inc. Shareholders Who Lost MoneyJune 11, 2025 | accessnewswire.comAnalysts Offer Predictions for Informatica FY2026 EarningsJune 10, 2025 | marketbeat.comInformatica Inc. Being Investigated on Behalf of Informatica Inc. Investors. Contact Levi & Korsinsky For DetailsJune 10, 2025 | accessnewswire.comInsider Selling: Informatica Inc. (NYSE:INFA) EVP Sells 99,348 Shares of StockJune 10, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHGEN, INFA, EPP, and JEL Company DescriptionsiShares MSCI Pacific ex Japan ETF NYSEARCA:EPP$48.34 +0.03 (+0.06%) As of 06/18/2025 04:10 PM EasterniShares MSCI Pacific ex Japan ET (the Fund), formerly iShares MSCI Pacific ex-Japan Index Fund, is an exchange-traded fund (ETF). The Fund seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Australia, Hong Kong, New Zealand and Singapore markets, as measured by the MSCI Pacific ex-Japan Index (the Index). The Fund invests in a representative sample of securities that collectively has an investment profile similar to the underlying index. The securities selected are expected to have, in aggregate , investment characteristics, fundamental characteristics and liquidity measures similar to those of the underlying index. The Fund's investment advisor is BlackRock Fund Advisors.Humanigen NASDAQ:HGENHumanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response. The company is developing lenzilumab, an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat cytokine storm associated with COVID-19 for which it has completed a Phase 3 study and is the focus of a Phase 2/3 study sponsored by the NIH. It is also developing lenzilumab, which is associated with CD19-targeted CAR-T cell therapies, as well as exploring the effectiveness of lenzilumab in other inflammatory conditions, such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation and in eosinophilic asthma, and rheumatoid arthritis. In addition, the company focuses on studying lenzilumab for patients with chronic myelomonocytic leukemia exhibiting RAS pathway mutations. Its pipeline also includes two other Humaneered monoclonal antibodies, ifabotuzumab, which binds to EphA3, and HGEN005, which targets EMR1, as well as treats a range of eosinophilic diseases, including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct. Humanigen, Inc. was incorporated in 2000 and is headquartered in Short Hills, New Jersey. On January 3, 2024, Humanigen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Informatica NYSE:INFA$24.16 -0.01 (-0.02%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$24.12 -0.04 (-0.14%) As of 06/18/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Informatica Inc. develops an artificial intelligence-powered platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at enterprise scale worldwide. Its platform includes a suite of interoperable data management products, including data integration products to ingest, transform, and integrate data; API and application integration products that enable users to create and manage APIs and integration processes for app-to-app synchronization, business process orchestration, B2B partner management, application development, and API management; data quality and observability products to profile, cleanse, standardize, observe, and monitor data to deliver accurate, complete, and consistent data; and master data management products to create an authoritative single source of truth of business-critical data. The company's platform also includes customer and business 360 application that allow business analysts to create 360-degree views of business data domains like customer, product, supplier, reference, and finance with simplified business user experiences; data catalog products that enables customers to quickly find, access, and understand enterprise data using a simple Google-like search experience; governance and privacy products that help users define policies, govern data, and ensure compliance with industry and corporate policies; and a data marketplace that delivers cloud shopping experience for data consumers and enables data sharing and AI models across organizations to facilitate data-driven decision making. It also offers maintenance and professional services. The company sells its products through its direct sales team. The company was founded in 1993 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
